Boehringer Ingelheim Page 2 of 14

Trajenta
Linagliptin, 5 mg film coated tablet

Response Document
Proprietary confidential information © 2017 Boehringer Ingelheim International GinbH or one or more of its affiliated companies

INTRODUCTION
The following document provides a response to the rejection of the addition of the new
indication "add- on to insulin" in a question and answer format with the corresponding
narrative answers following each comment from the National Agency of Drug and Food
Control of Republic of Indonesia.

INTRODUCTION